Literature DB >> 11244443

Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis.

M Yamaguchi1, M Kimura, Y Watanabe, M Taniguchi, M Masuya, S Kageyama, N Katayama, T Ohno, K Kita, H Shiku.   

Abstract

We describe a case of relapsed intravascular lymphomatosis (IVL) successfully treated with autologous PBSCT. A 59-year-old Japanese female patient with IVL who had achieved CR after six courses of biweekly CHOP therapy developed lymphoma. She achieved a second CR after six courses of modified biweekly CHOP therapy, followed by autologous PBSCH and high-dose chemotherapy (CBDCA, VP-16, MCNU, CY) with PBSCT. There has not been any evidence of recurrence 48 months after PBSCT. Our case suggests that PBSC is acceptable as a source for stem cell rescue in IVL.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11244443     DOI： 10.1038/sj.bmt.1702735

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  9 in total

1.  Intravascular lymphomatosis and intracerebral haemorrhage.

Authors:  Maria Grazia Passarin; Patrick Y Wen; Emanuela Vattemi; Ebba Buffone; Claudio Ghimenton; Lamberto Bontempini; Sarah Ottaviani; Anna Maria Musso; Rebecca Pedersini
Journal:  Neurol Sci       Date:  2010-06-02       Impact factor: 3.307

2.  Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.

Authors:  Yasufumi Masaki; Lingli Dong; Akio Nakajima; Haruka Iwao; Miyuki Miki; Nozomu Kurose; Eriko Kinoshita; Takayuki Nojima; Toshioki Sawaki; Takafumi Kawanami; Masao Tanaka; Kumiko Shimoyama; Changi Kim; Masaaki Fukutoku; Hiroshi Kawabata; Toshihiro Fukushima; Yuko Hirose; Tomoo Takiguchi; Susumu Konda; Susumu Sugai; Hisanori Umehara
Journal:  Int J Hematol       Date:  2009-04-14       Impact factor: 2.490

3.  Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.

Authors:  J Meissner; H Finel; S Dietrich; A Boumendil; E Kanfer; G Laboure; M Abecasis; J Cornelissen; J Delage; J Finke; U Hess; H Ludwig; M Mohty; T Pabst; P Pioltelli; S Robinson; P Samaras; S Montoto; P Dreger
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

4.  Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma.

Authors:  K Kato; Y Ohno; T Kamimura; H Kusumoto; T Tochigi; F Jinnouchi; K Kohno; T Kuriyama; H Henzan; K Takase; I Kawano; M Kadowaki; R Nawata; T Muta; T Eto; H Iawasaki; K Ohshima; T Miyamoto; K Akashi
Journal:  Bone Marrow Transplant       Date:  2014-08-18       Impact factor: 5.483

Review 5.  A new approach to the diagnosis and treatment of intravascular lymphoma.

Authors:  Joachim M Baehring; Janina Longtine; Fred H Hochberg
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

Review 6.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

7.  [Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease].

Authors:  I Satzger; B Völker; D Kofahl-Krause; A Ganser; A Kapp; R Gutzmer
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

8.  A Case of De Novo CD5+ Disseminated Intravascular Large B-Cell Lymphoma Presenting as Multiorgan Failure.

Authors:  Daulath Singh; Devika Kapuria; Suparna Nanua; Rakesh Gaur
Journal:  Case Rep Hematol       Date:  2016-09-29

Review 9.  Intravascular Large B-cell lymphoma: A case series and review of literatures.

Authors:  Yuen-Chin Ong; Hsiao-Wen Kao; Wen-Yu Chuang; Yu-Shin Hung; Tung-Liang Lin; Hung Chang; Ming-Chung Kuo
Journal:  Biomed J       Date:  2020-04-25       Impact factor: 4.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.